Kevin Francis Long

Title: Kevin Francis Long: Innovator in Pharmaceutical Formulations

Introduction

Kevin Francis Long is a notable inventor based in Flemington, NJ (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of stable solutions for medical applications. With a total of 2 patents, Long's work has the potential to impact the treatment of various health conditions.

Latest Patents

Kevin Long's latest patents include innovative formulations of 2-chloro-2'-deoxyadenosine (2-CdA). The first patent discloses shelf-stable formulations of 2-CdA in water that contain benzyl alcohol and, optionally, propylene glycol. The second patent presents stable 2-CdA formulations in water, which also include benzyl alcohol, m-cresol, a buffer, and sodium chloride or a solubilizing agent such as propylene glycol or polyethylene glycol. These advancements are crucial for ensuring the efficacy and stability of pharmaceutical products.

Career Highlights

Long is currently associated with Ortho Pharmaceutical Corporation, where he applies his expertise in pharmaceutical development. His work focuses on creating formulations that enhance the stability and usability of important medical compounds.

Collaborations

Some of his coworkers include Michael Bornstein and Rosemary Rozman, who contribute to the collaborative environment at Ortho Pharmaceutical Corporation. Their combined efforts help drive innovation in the pharmaceutical industry.

Conclusion

Kevin Francis Long is a dedicated inventor whose work in pharmaceutical formulations is paving the way for more effective medical treatments. His contributions are vital to the ongoing advancements in the field.